| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6KWX9X0Q5K |
| InChI Key | LNXBEIZREVRNTF-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H26O4 |
| Molecular Weight | 342.44 |
| AlogP | 4.05 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 66.76 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 25.0 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias | Phase 3 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 96609-16-4 |
| ChEMBL | CHEMBL2105019 |
| DrugBank | DB12448 |
| FDA SRS | 6KWX9X0Q5K |
| Guide to Pharmacology | 5885 |
| PubChem | 57112 |
| SureChEMBL | SCHEMBL140583 |